EGFR and colorectal carcinoma: The approach of targeting multiple knots on the same signaling pathway, defined vertical suppression, was also shown to be able to prevent the onset of resistance to anti-EGFR monoclonal antibodies in CRC by intercepting multiple mechanisms of acquired resistance to such agents [23].